European regulators are watching J&J's vaccine for unusual blood clots.
The European Medicines Agency is investigating reports of clots in people who received J&J's vaccine. The shot has not yet been given out in Europe.
European regulators are investigating whether Johnson & Johnson's COVID-19 vaccine caused unusual blood clotting after four cases were reported in vaccine recipients, including one fatality.
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee disclosed Friday that they are reviewing the vaccine after three people who received J&J's vaccine in the US and another who was involved in a clinical trial developed blood clots. It's currently not clear if the vaccine caused these clots.
J&J said that it was working closely with experts and regulators to assess data coming in, but that so far, they have found a small number of very rare side effects.
The investigation comes as European states prepare to add the vaccine to their roster of COVID-19 shots. J&J's vaccine
was recommended for authorization by the EMA on March 11, but has not yet been distributed.
Approximately 4.9 million doses of J&J's vaccine have been administered in the US,
according to the CDC.It's not the first time the link between vaccines and blood clots has been investigatedThe EMA has been closely watching reports of blood clots linked to another vaccine: AstraZeneca's two-dose immunization.The agency stated Wednesday that blood clots can be a "very rare" side effect of AstraZeneca's shot in people with low blood platelet levels. Approximately 169 cases of blood clots in the brain and 53 cases of blood clots in the spleen had been reported as of April 4, according to the EMA.Cases of blood clots have also reported in patients who had received Moderna and Pfizer's vaccines, a J&J spokesperson said in a statement.Issues have been popping up as J&J's shot has rolled out in the US.
One of the factories that produces both drug companies' vaccines is in hot water after it was reported by the New York Times that 15 million doses of Johnson & Johnson's vaccine had been cross-contaminated with AstraZeneca's vaccine at a U.S. factory run by Emergent BioSolutions. None of those shots were distributed to the public.Officials in
Colorado and North Carolina stopped giving out J&J's vaccine this week after two dozen people experienced minor adverse reactions like nausea and dizziness.
J&J's stock traded down about 1% on Friday morning.
Comment: It's interesting that any bad press coming out about the Covid vaccines is focusing specifically on the non-mRNA varieties. We know there are
potentially problems with the Pfizer vaccine given what is happening in Israel, but this not receiving much press. It seems clear the PTB would like steer as many people as possible into getting the mRNA variety by publicizing the adverse reactions in the non-mRNA vaccines (keeping in mind there are undoubtedly adverse reactions in
all vaccines), making them appear less safe. Wonder why?
The same appears to be happening to the AstraZeneca vaccine, also not an mRNA vaccine.
From RT:
Five cases of a very rare blood disorder in people who have received the Covid-19 vaccine developed by AstraZeneca are being reviewed by the European Medicines Agency (EMA), the EU's drug regulator has said.
The cases of "capillary leak syndrome," which can cause leakage of fluid from blood vessels, tissue swelling and a drop in blood pressure, were reported from across the European Economic Area, the EMA said on Friday.
The regulator said it is "not yet clear" if there is a causal association between AstraZeneca's Vaxzevria jab and the condition, which can cause organ failure if it is not treated.
The EMA said the five cases, all reported in the European Economic Area, warrant further investigation and potentially an update to the vaccine's product information, if deemed necessary by its Pharmacovigilance Risk Assessment Committee (PRAC).
The reports of capillary leak syndrome are the latest blow for AstraZeneca's vaccine after the EMA said this week that "unusual blood clots with low blood platelets" should be listed as very rare side effects of the jab.
See also:
who would trust the same corporation to rapidly develop a 'vaccine' for a disease that's not dangerous to most under a blanket of complete government immunity?
Are there that many retards out there?